A. Viswabandya

发表

Comparison of clinical outcomes of patients with relapsed acute promyelocytic leukemia induced with arsenic trioxide and consolidated with either an autologous stem cell transplant or an arsenic trioxide-based regimen.

Rajasekar Thirugnanam, B. George, E. Chendamarai, 2009, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Polymorphisms in the immunoregulatory genes are associated with hematopoietic recovery and increased susceptibility to bacterial infections in patients with thalassaemia major undergoing matched related hematopoietic stem cell transplantation.

B. George, K. Lakshmi, A. Viswabandya, 2012, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Synchronous presentation of chronic myeloid leukemia with carcinoma penis: a rare presentation.

A. Viswabandya, A. Ganapule, Vivi Srivasvas Tavaavaava, 2014, Journal of clinical and diagnostic research : JCDR.

Association of Factors influencing selection of upfront hematopoietic cell transplantation versus non-transplant therapies in Myelofibrosis: Transplant decisions in MF.

A. Viswabandya, J. Lipton, Vikas Gupta, 2021, Transplantation and cellular therapy.

Cellular immune reconstitution and its impact on clinical outcome in children with beta thalassemia major undergoing a matched related myeloablative allogeneic bone marrow transplant.

B. George, K. Lakshmi, A. Viswabandya, 2009, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Treatment of children with acute lymphoblastic leukemia in India using a BFM protocol

B. George, A. Viswabandya, M. Chandy, 2008, Pediatric blood & cancer.

Allogeneic stem cell transplant in myelodysplastic syndrome‐factors impacting survival

A. Viswabandya, E. Atenafu, J. Mattsson, 2019, European journal of haematology.

Therapeutic efficacy of azathioprine in addition to prednisone-based regimens as first-line chronic graft-versus-host disease treatment

J. Lipton, A. Viswabandya, H. Messner, 2017, Bone Marrow Transplantation.

Incidence and Risk Factors for Nontuberculous Mycobacterial Infection after Allogeneic Hematopoietic Cell Transplantation.

J. Lipton, A. Viswabandya, T. Marras, 2018, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Characteristics, treatment and outcomes of nontuberculous mycobacterial pulmonary disease after allogeneic haematopoietic stem cell transplant

J. Lipton, A. Viswabandya, T. Marras, 2018, European Respiratory Journal.

Asymptomatic gastrosplenic fistula in a patient with marginal zonal lymphoma transformed to diffuse large B cell lymphoma—a case report and review of literature

A. Viswabandya, Jayastu Senapati, A. Devasia, 2014, Annals of Hematology.

Cryotherapy for acute haemarthrosis in haemophilia – attempts to understand the ‘ice age’ practice

A. Viswabandya, A. Srivastava, J. A. David, 2015, Haemophilia : the official journal of the World Federation of Hemophilia.

Randomized, Double-Blind, Pharmacokinetic Equivalence Trial Comparing DRL-Rituximab With MabThera in Patients With Diffuse Large B-Cell Lymphoma

A. Viswabandya, A. Srivastava, A. Srivastava, 2019, Journal of global oncology.

Allogeneic hematopoietic stem cell transplantation in patients with therapy‐related hematologic malignancies developing after multiple myeloma

J. Lipton, A. Viswabandya, J. Mattsson, 2022, European journal of haematology.

Frequency of TPMT alleles in Indian patients with acute lymphatic leukemia and effect on the dose of 6-mercaptopurine

B. George, P. Balasubramanian, A. Viswabandya, 2010, Medical oncology.

Long-Term Incidence of Secondary Malignancies after Allogeneic Hematopoietic Cell Transplantation: A Single-Center Experience.

J. Lipton, A. Viswabandya, R. Kotchetkov, 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Non-Hodgkin lymphoma in childhood and adolescence: frequency and distribution of immunomorphological types from a tertiary care center in South India

A. Viswabandya, M. Chandy, A. Srivastava, 2011, World journal of pediatrics : WJP.

Effect of donor age and kinship on outcomes in haplo-identical stem cell transplantation may be modulated by GVHD prophylaxis strategies

J. Lipton, A. Viswabandya, M. Remberger, 2020, Bone Marrow Transplantation.

Effect of pre‐transplant JAK1/2 inhibitors and CD34 dose on transplant outcomes in myelofibrosis

J. Lipton, A. Viswabandya, S. Cyriac, 2021, European journal of haematology.

Psychometric analysis of the Functional Independence Score in Haemophilia (FISH)

A. Viswabandya, V. Mathews, A. Srivastava, 2007, Haemophilia : the official journal of the World Federation of Hemophilia.

Hepatotoxicity profile of single agent arsenic trioxide in the treatment of newly diagnosed acute promyelocytic leukemia, its impact on clinical outcome and the effect of genetic polymorphisms on the incidence of hepatotoxicity

B. George, K. Lakshmi, A. Viswabandya, 2006, Leukemia.

Molecular basis of quantitative fibrinogen disorders in 27 patients from India

B. George, A. Viswabandya, M. Chandy, 2013, Haemophilia : the official journal of the World Federation of Hemophilia.

Molecular basis of Bernard–Soulier syndrome in 27 patients from India

B. George, A. Viswabandya, M. Chandy, 2011, Journal of thrombosis and haemostasis : JTH.

Diagnosis and Management of von Willebrand Disease: A Developing Country Perspective

A. Viswabandya, A. Srivastava, S. Nair, 2011, Seminars in thrombosis and hemostasis.

Management of hemophilia in patients with inhibitors: the perspective from developing countries.

A. Viswabandya, A. Srivastava, V. Mathews, 2009, Seminars in thrombosis and hemostasis.

Reduced‐intensity conditioning allogeneic transplant with dual T‐cell depletion in myelofibrosis

J. Lipton, A. Viswabandya, J. Mattsson, 2019, European journal of haematology.

Ruxolitinib Therapy Followed by Reduced-Intensity Conditioning for Hematopoietic Cell Transplantation for Myelofibrosis: Myeloproliferative Disorders Research Consortium 114 Study.

A. Mead, M. Salama, A. Viswabandya, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Post-transplant ferritin level predicts outcomes after allogeneic hematopoietic stem cell transplant, independent from pre-transplant ferritin level

J. Lipton, A. Viswabandya, J. Mattsson, 2021, Annals of Hematology.

Population pharmacokinetics of cyclophosphamide in patients with thalassemia major undergoing HSCT

J. Panetta, B. George, K. Lakshmi, 2012, Bone Marrow Transplantation.

Adult ALL: treatment outcome and prognostic factors in an Indian population using a modified German ALL (GMALL) protocol

B. George, A. Viswabandya, M. Chandy, 2007, Leukemia.

Dapsone for chronic idiopathic thrombocytopenic purpura in children and adults – a report on 90 patients

B. George, A. Viswabandya, A. Srivastava, 2005, European journal of haematology.

Outcomes of adult patients with acute myeloid leukemia and unsuccessful cytogenetic analysis undergoing allogeneic hematopoietic stem cell transplantation.

J. Lipton, A. Viswabandya, J. Mattsson, 2020, Hematology/oncology and stem cell therapy.

Fludarabine and busulfan plus low-dose TBI as reduced intensity conditioning in older patients undergoing allogeneic hematopoietic cell transplant for myeloid malignancies

J. Lipton, A. Viswabandya, H. Messner, 2018, Annals of Hematology.

RNA expression of genes involved in cytarabine metabolism and transport predicts cytarabine response in acute myeloid leukemia.

B. George, K. Lakshmi, P. Balasubramanian, 2015, Pharmacogenomics.

The t(6;9)(p22;q34) in myeloid neoplasms: a retrospective study of 16 cases.

Monika Gupta, B. George, P. Balasubramanian, 2010, Cancer genetics and cytogenetics.

The 17‐gene stemness score associates with relapse risk and long‐term outcomes following allogeneic haematopoietic cell transplantation in acute myeloid leukaemia

M. Minden, Steven M. Chan, Tong Zhang, 2022, EJHaem.

Outcome of treatment with a low cost protocol in adults with T cell acute lymphoblastic leukemia in a tertiary care center in India

B. George, K. Lakshmi, A. Viswabandya, 2014, Leukemia & lymphoma.

Long-term outcome following splenectomy for chronic and persistent immune thrombocytopenia (ITP) in adults and children

B. George, K. Lakshmi, A. Viswabandya, 2016, Annals of Hematology.

Sorafenib Induced Hand Foot Skin Rash in FLT3 ITD Mutated Acute Myeloid Leukemia-A Case Report and Review of Literature

A. Viswabandya, A. Ganapule, Jayastu Senapati, 2014, Mediterranean journal of hematology and infectious diseases.

Predictors of outcomes of therapy-related acute myeloid leukemia after allogeneic hematopoietic stem cell transplantation.

J. Lipton, A. Viswabandya, J. Mattsson, 2021, Hematology/oncology and stem cell therapy.

The effectiveness of psychoeducational interventions on caregiver‐oriented outcomes in caregivers of adult cancer patients: A systematic review and meta‐analysis

A. Viswabandya, Charlotte T. Lee, E. Atenafu, 2022, Psycho-oncology.

Primary splenic marginal zone lymphoma with florid granulomatous reaction--a case report and review of literature.

A. Viswabandya, A. Srivastava, M. Manipadam, 2007, Pathology, research and practice.

Histiocytic Sarcoma with Acute Lymphoblastic Leukemia a Rare Association: Case Report and Literature Review

A. Viswabandya, Mayank Gupta, A. Ganapule, 2014, Indian Journal of Hematology and Blood Transfusion.

Outcomes of therapy‐related acute lymphoblastic leukemia in adults after allogeneic stem cell transplantation

J. Lipton, A. Viswabandya, J. Mattsson, 2020, European journal of haematology.

Choosing Wisely BMT: American Society for Blood and Marrow Transplantation and Canadian Blood and Marrow Transplant Group's List of 5 Tests and Treatments to Question in Blood and Marrow Transplantation.

A. Krishnan, A. Viswabandya, Z. DeFilipp, 2018, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Biology of Graft-Versus-Host Disease

A. Viswabandya, I. Novitzky-Basso, 2021, Contemporary Bone Marrow Transplantation.

Allogeneic blood or marrow transplantation with haploidentical donor and post-transplantation cyclophosphamide in patients with myelofibrosis: a multicenter study

A. Viswabandya, Richard J. Jones, M. Grunwald, 2021, Leukemia.

Myelofibrosis—When Do We Select Transplantation or Non-transplantation Therapeutic Options?

A. Viswabandya, Vikas Gupta, R. Devlin, 2016, Current Hematologic Malignancy Reports.

Successful surgical haemostasis in patients with von Willebrand disease with Koate®DVI

B. George, A. Viswabandya, M. Chandy, 2008, Haemophilia : the official journal of the World Federation of Hemophilia.

Dendritic cell count in the graft predicts relapse in patients with hematologic malignancies undergoing an HLA-matched related allogeneic peripheral blood stem cell transplant.

Rajasekar Thirugnanam, B. George, K. Lakshmi, 2010, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Post-Transplant Cyclophosphamide Combined with Anti-Thymocyte Globulin as Graft-versus-Host Disease Prophylaxis for Allogeneic Hematopoietic Cell Transplantation in High-Risk Acute Myeloid Leukemia and Myelodysplastic Syndrome

J. Lipton, A. Viswabandya, J. Mattsson, 2020, Acta Haematologica.

Reduced intensity allogeneic stem cell transplant with anti‐thymocyte globulin and post‐transplant cyclophosphamide in acute myeloid leukemia

J. Lipton, A. Viswabandya, E. Atenafu, 2019, European journal of haematology.

Impact of central nervous system involvement in AML on outcomes after allotransplant and utility of pretransplant cerebrospinal fluid assessment

J. Lipton, A. Viswabandya, E. Atenafu, 2019, European journal of haematology.

Influence of FLT3‐ITD and NPM1 status on allogeneic hematopoietic cell transplant outcomes in patients with cytogenetically normal AML

J. Lipton, A. Viswabandya, H. Messner, 2019, European journal of haematology.

Fibrinogen concentrate for treatment of bleeding and surgical prophylaxis in congenital fibrinogen deficiency patients

A. Viswabandya, C. Solomon, C. Djambas Khayat, 2019, Journal of thrombosis and haemostasis : JTH.

NK/T-cell lymphoma in a renal transplant recipient and review of literature

A. Viswabandya, G. John, A. Mohapatra, 2011, Indian journal of nephrology.

Plasmacytoid dendritic cell count on day 28 in HLA-matched related allogeneic peripheral blood stem cell transplant predicts the incidence of acute and chronic GVHD.

B. George, K. Lakshmi, A. Viswabandya, 2008, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Distinctive clinical characteristics and favorable outcomes in patients with large granular lymphocytosis after allo‐HCT: 12‐year follow‐up data

J. Lipton, A. Viswabandya, S. Sohn, 2017, European journal of haematology.

The mutational landscape of accelerated- and blast-phase myeloproliferative neoplasms impacts patient outcomes.

M. Minden, T. Panzarella, Steven M. Chan, 2018, Blood advances.

Limited benefit of pentostatin salvage therapy for steroid‐refractory grade III‐IV acute graft‐versus‐host disease

J. Lipton, A. Viswabandya, E. Atenafu, 2013, Clinical transplantation.

Molecular basis of Wiskott–Aldrich syndrome in patients from India

B. George, A. Viswabandya, M. Chandy, 2012, European journal of haematology.

ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION IS SUPERIOR TO IMMUNOSUPPRESSIVE THERAPY IN INDIAN CHILDREN WITH APLASTIC ANEMIA—A SINGLE-CENTER ANALYSIS OF 100 PATIENTS

B. George, K. Lakshmi, A. Viswabandya, 2010, Pediatric hematology and oncology.

Combination of the Centre for International Blood and Marrow Transplant Registry Risk Score and the Global Severity Score Enhances Prognostic Risk Stratification in Patients Receiving Frontline Therapy for Chronic Graft-versus-Host Disease.

J. Lipton, A. Viswabandya, H. Messner, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Hemostatic Abnormalities in Severe Renal Failure: Do They Bark or Bite?

S. Varughese, A. Viswabandya, S. Nair, 2018, Indian journal of nephrology.

Impact of hematopoietic cell transplant frailty scale on transplant outcome in adults

J. Lipton, A. Viswabandya, S. Alibhai, 2022, Bone Marrow Transplantation.

Improved Clinical Outcomes of High Risk β Thalassemia Major Patients Undergoing a HLA Matched Related Allogeneic Stem Cell Transplant with a Treosulfan Based Conditioning Regimen and Peripheral Blood Stem Cell Grafts

B. George, K. Lakshmi, A. Viswabandya, 2013, PloS one.

Infections in children undergoing allogeneic bone marrow transplantation in India

B. George, A. Viswabandya, M. Chandy, 2006, Pediatric transplantation.

Safety of two-hour intermittent intravenous infusions of tacrolimus in the allogeneic hematopoietic stem cell transplantation unit

J. Lipton, A. Viswabandya, H. Messner, 2018, Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners.

Relationship between certain HLA alleles and the risk of cytomegalovirus reactivation following allogeneic hematopoietic stem cell transplantation

J. Lipton, A. Viswabandya, M. Remberger, 2022, Transplant infectious disease : an official journal of the Transplantation Society.

Post-transplant cyclophosphamide combined with anti-thymocyte globulin for graft-vs-host disease prophylaxis improves survival and lowers non-relapse mortality in older patients undergoing allogeneic hematopoietic cell transplantation

J. Lipton, A. Viswabandya, J. Mattsson, 2020, Annals of Hematology.

Low rates of acute and chronic GVHD with ATG and PTCy in matched and mismatched unrelated donor peripheral blood stem cell transplants

A. Viswabandya, E. Atenafu, A. Law, 2019, European journal of haematology.

Safety and Efficacy of Haploidentical Peripheral Blood Stem Cell Transplantation for Myeloid Malignancies Using Post-transplantation Cyclophosphamide and Anti-thymocyte Globulin as Graft-versus-Host Disease Prophylaxis

J. Lipton, A. Viswabandya, J. Mattsson, 2019, Clinical hematology international.

Reduced-Intensity Conditioning and Dual T Lymphocyte Suppression with Antithymocyte Globulin and Post-Transplant Cyclophosphamide as Graft-versus-Host Disease Prophylaxis in Haploidentical Hematopoietic Stem Cell Transplants for Hematological Malignancies

J. Lipton, A. Viswabandya, H. Messner, 2018, Biology of Blood and Marrow Transplantation.

Short communication The t(6;9)(p22;q34) in myeloid neoplasms: a retrospective study of 16 cases

Monika Gupta, B. George, P. Balasubramanian, 2010 .

Efficacy of Cidofovir in Treatment of BK Virus-Induced Hemorrhagic Cystitis in Allogeneic Hematopoietic Cell Transplant Recipients.

J. Lipton, A. Viswabandya, E. Coomes, 2018, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Fludarabine based reduced intensity conditioning regimens in children undergoing allogeneic stem cell transplantation for severe aplastic anemia

B. George, A. Viswabandya, M. Chandy, 2008, Pediatric transplantation.

Fludarabine and cyclophosphamide based reduced intensity conditioning (RIC) regimens reduce rejection and improve outcome in Indian patients undergoing allogeneic stem cell transplantation for severe aplastic anemia

B. George, A. Viswabandya, M. Chandy, 2007, Bone Marrow Transplantation.

Polymorphism in factor VII gene modifies phenotype of severe haemophilia

B. George, K. Lakshmi, A. Viswabandya, 2009, Haemophilia : the official journal of the World Federation of Hemophilia.

A patient‐prioritized ability assessment in haemophilia: the Canadian Occupational Performance Measure

A. Viswabandya, V. Mathews, A. Srivastava, 2011, Haemophilia : the official journal of the World Federation of Hemophilia.

Dose and outcome of care in haemophilia – how do we define cost‐effectiveness?

A. Viswabandya, V. Mathews, K. Fischer, 2004, Haemophilia : the official journal of the World Federation of Hemophilia.

Comprehensive Care and Delivery of Care in Hemophilia: The Developing World

A. Viswabandya, A. Srivastava, 2014 .

Fracture neck of femur in haemophilia A – experience from a cohort of 11 patients from a tertiary centre in India

B. George, A. Viswabandya, M. Chandy, 2007, Haemophilia.

Six novel mutations including triple heterozygosity for Phe31Ser, 514delT and 516T→G factor X gene mutations are responsible for congenital factor X deficiency in patients of Nepali and Indian origin

B. George, A. Viswabandya, M. Chandy, 2005, Journal of thrombosis and haemostasis : JTH.

Surgery for hemophilia in developing countries.

B. George, A. Viswabandya, M. Chandy, 2005, Seminars in thrombosis and hemostasis.

Role of endovascular embolization in treatment of acute bleeding complications in haemophilia patients.

B. George, A. Viswabandya, V. Mathews, 2016, The British journal of radiology.

BJRD151064 1..7

B. George, A. Viswabandya, V. Mathews, 2016 .

Pheochromocytoma and haemophilia: an unusual combination.

A. Viswabandya, T. Paul, D. Abraham, 2009, Singapore medical journal.

Comprehensive Care and Delivery of Care: The Developing World

A. Viswabandya, A. Srivastava, 2007 .

Type‐3 von Willebrand disease in India—Clinical spectrum and molecular profile

B. George, A. Viswabandya, A. Biswas, 2018, Haemophilia : the official journal of the World Federation of Hemophilia.

Correlating clinical manifestations with factor levels in rare bleeding disorders: a report from Southern India

B. George, A. Viswabandya, M. Chandy, 2012, Haemophilia : the official journal of the World Federation of Hemophilia.

Mutations in the MCFD2 gene are predominant among patients with hereditary combined FV and FVIII deficiency (F5F8D) in India

A. Viswabandya, M. Chandy, G. Jayandharan, 2007, Haemophilia : the official journal of the World Federation of Hemophilia.

Should ice be used in the treatment of acute haemarthrosis in haemophilia?

A. Viswabandya, A. Srivastava, M. Rajamanickam, 2013, Haemophilia : the official journal of the World Federation of Hemophilia.

Preliminary experience with use of recombinant activated factor VII to control postpartum hemorrhage in acute fatty liver of pregnancy and other pregnancy-related liver disorders

A. Viswabandya, G. Chandy, S. Nair, 2013, Indian Journal of Gastroenterology.

Single-agent arsenic trioxide in the treatment of newly diagnosed acute promyelocytic leukemia: durable remissions with minimal toxicity.

B. George, K. Lakshmi, P. Balasubramanian, 2006, Blood.

Treatment of Acute Promyelocytic Leukemia with Single-Agent Arsenic Trioxide

B. George, E. Chendamarai, A. Viswabandya, 2011, Mediterranean journal of hematology and infectious diseases.

Invasive fungal infection following chemotherapy for acute myeloid leukaemia—Experience from a developing country

B. George, K. Lakshmi, A. Viswabandya, 2017, Mycoses.

Acute myeloid leukaemia: challenges and real world data from India

B. George, K. Lakshmi, P. Balasubramanian, 2015, British journal of haematology.

Letermovir as Salvage Therapy for CMV Infection in Transplant Recipients.

Deepali Kumar, A. Humar, A. Viswabandya, 2020, Transplantation.

Developing an algorithm of informative markers for evaluation of chimerism after allogeneic bone marrow transplantation

B. George, P. Balasubramanian, A. Viswabandya, 2006, Bone Marrow Transplantation.

Fludarabine Based Conditioning for Allogeneic Transplantation in Severe Aplastic Anemia.

B. George, A. Viswabandya, M. Chandy, 2005 .

Long-term outcome of mixed chimerism after stem cell transplantation for thalassemia major conditioned with busulfan and cyclophosphamide

B. George, K. Lakshmi, P. Balasubramanian, 2018, Bone Marrow Transplantation.

Impact of pretransplant splenectomy on patients with β‐thalassemia major undergoing a matched‐related allogeneic stem cell transplantation

B. George, K. Lakshmi, A. Viswabandya, 2009, Pediatric transplantation.

A new stratification strategy that identifies a subset of class III patients with an adverse prognosis among children with beta thalassemia major undergoing a matched related allogeneic stem cell transplantation.

B. George, K. Lakshmi, A. Viswabandya, 2007, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Pharmacokinetics and Pharmacodynamics of Treosulfan in Patients With Thalassemia Major Undergoing Allogeneic Hematopoietic Stem Cell Transplantation

J. Panetta, B. George, K. Lakshmi, 2018, Clinical pharmacology and therapeutics.

Clinical manifestations of combined factor V and VIII deficiency: A series of 37 cases from a single center in India†

B. George, K. Lakshmi, A. Viswabandya, 2010, American journal of hematology.

Glioblastoma Multiforme in a Post Allogeneic Stem Cell Transplant Patient. A Case Report and Literature Review of Post Transplant Neurological Tumors

A. Viswabandya, Geeta Chacko, A. Ganapule, 2016, Indian Journal of Hematology and Blood Transfusion.

Cytogenetic analysis of acute myeloid leukemia with t(8;21) from a tertiary care center in India with correlation between clinicopathologic characteristics and molecular analysis

B. George, P. Balasubramanian, A. Viswabandya, 2012, Leukemia & lymphoma.

Efficacy and cost analysis of eltrombopag in thrombocytopenia and poor graft function post allogeneic hematopoietic cell transplantation

J. Lipton, A. Viswabandya, J. Mattsson, 2021, Bone Marrow Transplantation.

Clinicopathological features of hepatosplenic T cell lymphoma: a single centre experience from India

B. George, A. Viswabandya, V. Mathews, 2012, Leukemia & lymphoma.

Spectrum of BCR-ABL kinase domain mutations in patients with chronic myeloid leukemia from India with suspected resistance to imatinib-mutations are rare and have different distributions

B. George, E. Chendamarai, P. Balasubramanian, 2009, Leukemia & lymphoma.

A systematic review comparing allogeneic hematopoietic stem cell transplant to gene therapy in sickle cell disease

A. Viswabandya, C. Patriquin, Christopher J. Patriquin, 2023, Hematology.

Molecular basis of hereditary factor V deficiency in India: Identification of four novel mutations and their genotype-phenotype correlation

B. George, A. Viswabandya, V. Mathews, 2011, Thrombosis and Haemostasis.

Fresh vs. frozen allogeneic peripheral blood stem cell grafts: A successful timely option

J. Lipton, A. Viswabandya, J. Mattsson, 2020, American journal of hematology.

Salvage with a mini-allograft after primary engraftment failure following autologous transplant for multiple myeloma

B. George, A. Viswabandya, M. Chandy, 2007, Bone Marrow Transplantation.

Impact of CD34+ cell dose on reduced intensity conditioning regimen haploidentical hematopoietic stem cell transplantation

J. Lipton, A. Viswabandya, E. Atenafu, 2019, European journal of haematology.

Anti‐thymocyte globulin and post‐transplant cyclophosphamide predisposes to inferior outcome when using cryopreserved stem cell grafts

J. Lipton, A. Viswabandya, M. Remberger, 2021, European journal of haematology.

Comparison of outcomes after second allogeneic hematopoietic cell transplantation versus donor lymphocyte infusion in allogeneic hematopoietic cell transplant patients

J. Lipton, A. Viswabandya, J. Mattsson, 2021, Clinical Lymphoma Myeloma and Leukemia.

Impact of comorbidities constituting the hematopoietic cell transplant (HCT)‐comorbidity index on the outcome of patients undergoing allogeneic HCT for acute myeloid leukemia

J. Lipton, A. Viswabandya, E. Atenafu, 2018, European journal of haematology.

Clinical prevalence and outcome of cardiovascular events in the first 100 days postallogeneic hematopoietic stem cell transplant

J. Lipton, A. Viswabandya, E. Atenafu, 2020, European journal of haematology.

Dual T-cell depletion with ATG and PTCy for peripheral blood reduced intensity conditioning allo-HSCT results in very low rates of GVHD

J. Lipton, A. Viswabandya, E. Atenafu, 2020, Bone Marrow Transplantation.

Experience Using Anti-Thymocyte Globulin With Post-Transplantation Cyclophosphamide for Graft-Versus-Host Disease Prophylaxis in Peripheral Blood Haploidentical Stem Cell Transplantation.

J. Lipton, A. Viswabandya, E. Atenafu, 2021, Transplantation and cellular therapy.

Lower dose of ATG combined with post-transplant cyclophosphamide for HLA matched RIC alloHCT is associated with effective control of GVHD and less viral infections

J. Lipton, A. Viswabandya, E. Atenafu, 2021, Leukemia & lymphoma.

IMPROVING SAFETY AND OUTCOMES AFTER ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION: A SINGLE-CENTRE EXPERIENCE.

J. Lipton, A. Viswabandya, M. Remberger, 2022, Transplantation and cellular therapy.

Comparison of the Prognostic Ability of the HCT-CI, the Modified EBMT, and the EBMT-ADT Pre-transplant Risk Scores for Acute Leukemia.

J. Lipton, A. Viswabandya, S. Cyriac, 2021, Clinical lymphoma, myeloma & leukemia.

Increased Incidence of Mixed Chimerism with the Use of Fludarabine – Treosulfan Based Conditioning in Patients Undergoing Allogeneic Stem Cell Transplantation for Thalassaemia Major

B. George, A. Viswabandya, V. Mathews, 2015 .

Population pharmacokinetics of fludarabine in patients with aplastic anemia and Fanconi anemia undergoing allogeneic hematopoietic stem cell transplantation

J. Panetta, B. George, K. Lakshmi, 2017, Bone Marrow Transplantation.

The use of a fludarabine‐based conditioning regimen in patients with severe aplastic anemia – a retrospective analysis from three Indian centers

B. George, K. Lakshmi, A. Viswabandya, 2013, Clinical transplantation.

My jamais vu in post allogeneic hematopoietic cell transplant: a review on secondary hemophagocytosis in adults

J. Lipton, A. Viswabandya, F. Michelis, 2019, Bone Marrow Transplantation.

HIV-associated lymphoma: A 5-year clinicopathologic study from India

A. Viswabandya, A. Zachariah, M. Manipadam, 2019, Indian journal of pathology & microbiology.

HSCT in Malignancies

A. Viswabandya, M. Salas, 2020, Contemporary Bone Marrow Transplantation.

Single-agent arsenic trioxide in the treatment of newly diagnosed acute promyelocytic leukemia: long-term follow-up data.

B. George, E. Chendamarai, K. Lakshmi, 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Incidence and Risk Factors for Nontuberculous Mycobacteria Infection after Allogeneic Hematopoietic Cell Transplantation

J. Lipton, A. Viswabandya, T. Marras, 2015 .

Bloodstream Infections and Outcomes Following Allogeneic Hematopoietic Cell Transplantation: a Single-Center Study.

J. Lipton, A. Viswabandya, M. Remberger, 2021, Transplantation and cellular therapy.

Peripheral T cell lymphoma: Clinico-pathological characteristics & outcome from a tertiary care centre in south India

B. George, A. Viswabandya, V. Mathews, 2018, The Indian journal of medical research.

The t(8;14)(q24.1;q32) and its variant translocations: A study of 34 cases.

B. George, A. Viswabandya, V. Mathews, 2017, Hematology/oncology and stem cell therapy.

Granulocytic sarcoma with compressive myelopathy: a rare presentation of chronic myelogenous leukemia.

A. Viswabandya, A. Ganapule, A. Jasper, 2014, Journal of clinical and diagnostic research : JCDR.

Outcomes of patients diagnosed with chronic lymphocytic leukemia after allogeneic hematopoietic stem cell transplantation: Results from a tertiary care center.

J. Lipton, A. Viswabandya, J. Mattsson, 2021, Hematology/oncology and stem cell therapy.

Impact of age on hospitalization and outcomes post allogeneic hematopoietic cell transplantation outcome, a single center experience

J. Lipton, A. Viswabandya, I. Novitzky-Basso, 2023, Annals of Hematology.

Pilot prospective study of Frailty and Functionality in routine clinical assessment in allogeneic hematopoietic cell transplantation

J. Lipton, A. Viswabandya, E. Atenafu, 2020, Bone Marrow Transplantation.

Mobilization of Leukemic Cells Using Plerixafor as Part of a Myeloablative Preparative Regimen for Patients with Acute Myelogenous Leukemia Undergoing Allografting: Assessment of Safety and Tolerability.

D. Hedley, J. Lipton, A. Viswabandya, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

High incidence but low mortality of EBV-reactivation and PTLD after alloHCT using ATG and PTCy for GVHD prophylaxis

Deepali Kumar, J. Lipton, A. Viswabandya, 2020, Leukemia & lymphoma.

Outcome following second allogeneic hematopoietic cell transplantation: A single‐center experience

J. Lipton, A. Viswabandya, H. Messner, 2018, European journal of haematology.

ATR-X syndrome in two siblings with a novel mutation (c.6718C>T mutation in exon 31)

A. Viswabandya, S. Thakur, R. Saxena, 2011, The Indian journal of medical research.

Role of minimal residual disease monitoring in acute promyelocytic leukemia treated with arsenic trioxide in frontline therapy.

B. George, E. Chendamarai, K. Lakshmi, 2011, Blood.

Prolactin, a potential biomarker for chronic GVHD activity

S. Ezzat, J. Lipton, A. Viswabandya, 2020, European journal of haematology.

Pretransplant bone marrow cellularity and blood count recovery are not associated with relapse or survival risk following allogeneic stem cell transplant for AML in CR

J. Lipton, A. Viswabandya, J. Mattsson, 2021, European journal of haematology.

Less is More: Superior GVHD-Free/Relapse-Free Survival with Reduced Intensity Conditioning and Dual T-cell Depletion in AML.

A. Viswabandya, J. Mattsson, F. Michelis, 2020, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Fludarabine‐based reduced intensity conditioning regimens for allogeneic hematopoietic stem cell transplantation in patients with aplastic anemia and fungal infections

B. George, A. Viswabandya, M. Chandy, 2009, Clinical transplantation.

High Overall and GVHD-Free Survival in Patients with Aplastic Anemia Receiving in vivo T-cell Depletion Transplants and Long-Term Complications.

J. Lipton, A. Viswabandya, E. Atenafu, 2020, Blood cell therapy.

Impact of comorbidities constituting the HCT-CI score on the outcome of patients undergoing allogeneic HCT for AML.

J. Lipton, A. Viswabandya, E. Atenafu, 2017 .

Prognostic impact of the adverse molecular-genetic profile on long-term outcomes following allogeneic hematopoietic stem cell transplantation in acute myeloid leukemia

M. Minden, Zhaolei Zhang, Steven M. Chan, 2021, Bone Marrow Transplantation.

Risk factors for graft failure in allogeneic hematopoietic stem cell transplantation: a single-center study

A. Viswabandya, M. Remberger, J. Lipton, 2020, Cellular Therapy and Transplantation.

Anti‐thymocyte Globulin and Post‐Transplant Cyclophosphamide do not abrogate the inferior outcome risk conferred by human leukocyte antigen‐A and ‐B mismatched donors

J. Lipton, A. Viswabandya, M. Remberger, 2021, European journal of haematology.

Allogeneic Hematopoietic Stem Cell Transplantation in Therapy Related Acute Leukemia

A. Viswabandya, Ram Vasudevan Nampoothiri, 2020, Indian Journal of Hematology and Blood Transfusion.

Reduction of severe acute graft-versus-host disease using a combination of pre transplant anti-thymocyte globulin and post-transplant cyclophosphamide in matched unrelated donor transplantation

J. Lipton, A. Viswabandya, E. Atenafu, 2018, Bone Marrow Transplantation.

Immunosuppressive Therapy and Bone Marrow Transplantation for Aplastic Anaemia--The CMC Experience.

B. George, A. Viswabandya, M. Chandy, 2015, The Journal of the Association of Physicians of India.

Allogeneic Hematopoietic Cell Transplantation for Adult T Cell Acute Lymphoblastic Leukemia.

C. Flowers, M. Perales, A. Viswabandya, 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Moderate-severe grade of chronic graft versus host disease and younger age (less than 45 years old) are risk factors for avascular necrosis in adult patients undergoing allogeneic hematopoietic cell transplantation

J. Lipton, A. Viswabandya, S. Bhella, 2015, Annals of Hematology.

Single Agent Arsenic Trioxide in the Treatment of Newly Diagnosed Acute Promyelocytic Leukemia: Long Term Follow-up Data.

B. George, E. Chendamarai, K. Lakshmi, 2009 .

Dual T Cell Depletion with Anti-Thymocyte Globulin and Post-Transplant Cyclophosphamide Results in Low Rates of Cytokine Release Syndrome in Peripheral Blood Haplo-Hematopoietic Stem Cell Transplantation

A. Viswabandya, A. Law, W. Lam, 2019 .

Atypical BCR-ABL1 fusion transcripts in adult B-acute lymphoblastic leukemia, including a novel fusion transcript-e8a1

B. George, P. Balasubramanian, A. Viswabandya, 2016, Leukemia & lymphoma.

Surgical procedures in patients with Glanzmann's thrombasthenia: case series and literature review

B. George, A. Viswabandya, V. Mathews, 2016, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

Molecular genetics of hereditary prothrombin deficiency in Indian patients: identification of a novel Ala362→Thr (Prothrombin Vellore 1) mutation

A. Viswabandya, M. Chandy, G. Jayandharan, 2005, Journal of thrombosis and haemostasis : JTH.

Subcutaneous immunoglobulin in allogeneic hematopoietic cell transplant patients: A prospective study of feasibility, safety, and healthcare resource use.

G. Dranitsaris, J. Lipton, A. Viswabandya, 2021, Hematology/oncology and stem cell therapy.

A unique case of tuberculosis dissemination presenting as cutaneous lesions in a post allogeneic stem cell transplant patient

J. Lipton, A. Viswabandya, H. Messner, 2016, Bone Marrow Transplantation.

Molecular basis of hereditary factor VII deficiency in India: five novel mutations including a double missense mutation (Ala191Glu; Trp364Cys) in 11 unrelated patients.

A. Viswabandya, M. Chandy, G. Jayandharan, 2007, Haematologica.

Refined hepatic grading system in chronic graft‐versus‐host disease improves prognostic risk stratification of long‐term outcomes

J. Lipton, A. Viswabandya, J. Mattsson, 2021, European journal of haematology.

Dual T-cell Depletion with ATG and PTCy Results in Low Rates of Cytokine Release Syndrome in Peripheral Blood Haplo-HSCT.

A. Viswabandya, A. Law, W. Lam, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Evaluation of a patient self-medication program in allogeneic hematopoietic stem cell transplantation

A. Viswabandya, Ian Pang, Celina Dara, 2021, Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners.

Progressive Multifocal Leukoencephalopathy due to John Cunningham (JC) virus following Allogeneic Haematopoietic Cell Transplantation

Deepali Kumar, J. Lipton, A. Viswabandya, 2017, Antiviral therapy.

Haploidentical Donor Blood or Marrow Transplantation for Myelodysplastic/Myeloproliferative Overlap Neoplasms: Results from a North American Collaboration

Shannon R. McCurdy, R. Varadhan, L. Gondek, 2023, Research square.

A short tale of blood, kidney and brain: BK virus encephalitis in an allogeneic stem cell transplant recipient

J. Lipton, A. Viswabandya, H. Messner, 2017, Bone Marrow Transplantation.

Haploidentical donor hematopoietic cell transplantation for myelodysplastic/myeloproliferative overlap neoplasms: results from a North American collaboration.

Shannon R. McCurdy, R. Varadhan, L. Gondek, 2023, Haematologica.

Clonal hematopoiesis in the donor does not adversely affect long-term outcomes following allogeneic hematopoietic stem cell transplantation: result from a 13-year follow-up

T. Biezuner, Zhaolei Zhang, J. Lipton, 2023, Haematologica.

Letermovir as Salvage Therapy for Cytomegalovirus Infection in Transplant Recipients.

Deepali Kumar, A. Humar, A. Viswabandya, 2020 .

Acute Graft Versus Host Disease Following Sibling Donor Transplantation for Thalassemia Major

B. George, K. Lakshmi, A. Viswabandya, 2014 .

Interaction between High-Dose Intravenous Busulfan and Post-Transplant Cyclophosphamide on Hemorrhagic Cystitis after Allogeneic Hematopoietic Cell Transplantation.

J. Lipton, A. Viswabandya, T. Mazzulli, 2023, Transplantation and cellular therapy.

Extramedullary disease at diagnosis of AML does not influence outcome of patients undergoing allogeneic hematopoietic cell transplant in CR1

J. Lipton, A. Viswabandya, J. Kuruvilla, 2017, European journal of haematology.

Dapsone, danazol, and intrapartum splenectomy in refractory ITP complicating pregnancy.

A. Viswabandya, L. Varghese, A. Mathew, 2008, Indian journal of medical sciences.

Comparison of the Efficacy of Innovator Rituximab and its Biosimilars in Diffuse Large B Cell Lymphoma Patients: A Retrospective Analysis

B. George, A. Viswabandya, V. Mathews, 2019, Indian Journal of Hematology and Blood Transfusion.

Alprazolam poisoning.

A. Viswabandya, S. Patnaik, B. Parija, 1999, Journal of Association of Physicians of India.

Polymorphisms in Coagulant and Inflammatory Genes Modify the Phenotype of Severe Hemophilia A and B.

A. Viswabandya, M. Chandy, V. Mathews, 2006 .

Allogeneic Stem Cell Transplantation Has Limited Benefit in Older Patients with Mixed Phenotype Acute Leukemia

M. Minden, Steven M. Chan, J. Lipton, 2019, Biology of Blood and Marrow Transplantation.

Mutational profile, outcomes, and impact of allogeneic hematopoietic stem cell transplantation in adult patients with acute myeloid leukemia and inconclusive cytogenetic analysis

M. Minden, Steven M. Chan, J. Lipton, 2023, European journal of haematology.

Mutations in coagulation factor XIII A gene in eight unrelated Indians

B. George, A. Viswabandya, M. Chandy, 2006, Thrombosis and Haemostasis.

ATG-Ptcy-CSA for Gvhd Prevention in Peripheral Blood Haploidentical Hematopoietic Cell Transplantation for Adults with Hematological Malignancies

J. Lipton, A. Viswabandya, E. Atenafu, 2022, Blood.

Ptcy-ATG-CSA Vs. ATG-MMF-CSA for Gvhd Prevention for 10/10 HLA Matched Unrelated Donor Allogeneic Hematopoietic Cell Transplantation

J. Lipton, A. Viswabandya, E. Atenafu, 2022, Blood.

Hepatobiliary and pancreatic: Spur cell anemia associated with alcoholic cirrhosis

A. Viswabandya, A. Goel, C. Eapen, 2008, Journal of gastroenterology and hepatology.

Prognostic implication of pre-transplant FEV1 on long-term outcomes following allogeneic hematopoietic stem cell transplantation.

J. Lipton, A. Viswabandya, T. Marras, 2023, European journal of haematology.

Treatment of Acute Promyelocytic Leukemia with Single-Agent Arsenic Trioxide

B. George, E. Chendamarai, A. Viswabandya, 2011, Mediterranean journal of hematology and infectious diseases.

B. George, K. Lakshmi, A. Viswabandya, 2012, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Propensity score matching analysis comparing the efficacy and steroid tapering benefit of extracorporeal photopheresis to best available therapy in third-line or beyond treatment for chronic GvHD.

A. Viswabandya, Christopher J. Patriquin, I. Novitzky-Basso, 2023, Transplantation and cellular therapy.

Single centre retrospective analysis of extracorporeal photopheresis (ECP) therapy in patients heavily pre-treated for chronic graft-versus-host disease (cGvHD) with steroid failure.

A. Viswabandya, Christopher J. Patriquin, I. Novitzky-Basso, 2023, Leukemia research.

Influence of conditioning regimen intensity on outcomes post‐allogeneic hematopoietic cell transplantation for acute myeloid leukemia in complete morphological remission

J. Lipton, A. Viswabandya, M. Remberger, 2023, European journal of haematology.

Reduction of severe acute graft-versus-host disease using a combination of pre transplant anti-thymocyte globulin and post-transplant cyclophosphamide in matched unrelated donor transplantation

J. Lipton, A. Viswabandya, E. Atenafu, 2018, Bone Marrow Transplantation.

Extramedullary plasmacytoma: an unusual neoplasm in a HIV-positive patient

A. Viswabandya, E. Sigamani, S. Pulimood, 2016, International journal of STD & AIDS.

Advances in Allogeneic Hematopoietic Stem Cell Transplantation for Acute Leukemia

A. Viswabandya, Y. Nannya, P. Lu, 2022, Blood cell therapy.

J. Lipton, A. Viswabandya, S. Bhella, 2021, Annals of Hematology.

HCT frailty scale for younger and older adults undergoing allogeneic hematopoietic cell transplantation

J. Lipton, A. Viswabandya, S. Alibhai, 2023, Bone Marrow Transplantation.

Outcomes of intensive and nonintensive blast-reduction strategies in accelerated and blast-phase MPN

M. Minden, A. Viswabandya, A. Schimmer, 2024, Blood Advances.

Upfront allogeneic transplantation versus JAK inhibitor therapy for patients with myelofibrosis: a North American collaborative study

M. Arcasoy, A. Viswabandya, S. Cerquozzi, 2023, Bone Marrow Transplantation.

Outcomes of ATG-PTCY-CSA vs. ATG-based Prophylaxis for 10/10 HLA Matched Unrelated Donor Allogeneic Hematopoietic Cell Transplantation: ATG-PTCY-CsA for PB MUD allo-HCT.

A. Viswabandya, E. Atenafu, I. Novitzky-Basso, 2024, Transplantation and cellular therapy.

Dual T cell depletion for graft versus host disease prevention in peripheral blood haploidentical hematopoietic cell transplantation for adults with hematological malignancies.

A. Viswabandya, E. Atenafu, A. Law, 2024, Bone marrow transplantation.

Choosing between older matched sibling donor and younger matched unrelated donor in allogeneic hematopoietic cell transplantation: comparison of clinical outcomes in acute myeloid leukemia and myelodysplastic syndrome.

J. Lipton, A. Viswabandya, M. Remberger, 2023, Transplantation and cellular therapy.